Bavarian keeps working on cancer treatments despite another setback
Although Bavarian Nordic haven't had much luck in their efforts to produce cancer treatments, the new vaccine purchase by the company should not be seen as a step away from the cancer field.
BY ELIZABETH MØNSTED JOHANSEN
It is sometimes easy to forget that Bavarian Nordic works with more than just infectious diseases. The company has generated big headlines in this area, but also has several studies in progress within their secondary focus area of cancer.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
